Verified#101554
PT-141
Advancing Research in Human Performance and Desire
$31 - $245Australia & New ZealandShips Australia, New Zealand
Product overview
Wholesale peptide supplier listing
Retatrutide is a next-generation peptide engineered to target three major metabolic receptors — GIP, GLP-1, and glucagon — supporting advanced metabolic and body composition research.
Public clinical investigations have demonstrated significant weight reduction potential, with trial participants reaching up to 17.5% body weight reduction within 24 weeks under controlled study conditions.
Retatrutide research is commonly associated with appetite regulation, metabolic optimisation, insulin sensitivity pathways, and sustained fat metabolism analysis.
This Vital Edge Science research batch features ultra-pure Retatrutide with 99.3%+ Janoshik-verified purity, supported by public batch verification and Australia/New Zealand fulfilment.
Recommended for reconstitution using bacteriostatic water within a pH range of 5.7 to 7.0.
Each vial contains 10mg~30mg of research-grade Retatrutide depending on selected variant.
For research use only.
Variants
Available MG variants
10MG × 1$78 USD1 vials · 10MG each
10MG × 10$532 USD10 vials · 10MG each
15MG × 1$106 USD1 vials · 15MG each
15MG × 10$887 USD10 vials · 15MG each
20MG × 1$142 USD1 vials · 20MG each
20MG × 10$1242 USD10 vials · 20MG each
30MG × 1$213 USD1 vials · 30MG each
30MG × 10$1768 USD10 vials · 30MG each
Verification report
Open ReportPublic report image
